Fig. 5From: N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapiesN6-methyladenosine and cancer metabolic reprogramming. a m6A modification can participate in the glycolysis process by affecting the RNA fate of key enzymes involved in the glycolysis process. b The m6A modification can also inhibit the aerobic respiration of cells, allowing more glucose to participate in glycolysisBack to article page